TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CIMPLRX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

CIMPLRX

ST13

US500000097077402

Class

9, 42

Filing

97077402

Registration

7602990

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

12/17/2024

Classification

Registered

Trademark type

Word

Nice classes

9, 42

Filing date

10/15/2021

Registration date

12/17/2024

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

12/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

03

Owner location

Seocho-gu, Seoul, KR

Examiner

SPARACINO, MARK V

Law office

L30

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Cimplrx Co., Ltd.

Representatives

Boris Umansky LADAS & PARRY LLP

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Downloadable computer software for drug discovery; downloadable computer programs for drug discovery; downloadable computer software for diagnosing diseases for medical purposes; recorded computer software for drug discovery; recorded computer programs for drug discovery; recorded computer software for diagnosing diseases for medical purposes; downloadable data processing software; recorded data processing software; downloadable computer software to enable searching of data; recorded computer software to enable searching of data; downloadable database management software applications; downloadable computer software for creating searchable databases; recorded computer software for creating searchable databases; downloadable computer software for accessing information directories that may be downloaded from the global computer network; recorded computer software for accessing information directories that may be downloaded from the global computer network; downloadable computer software for use in providing multiple user access to a global computer information network; recorded computer software for use in providing multiple user access to a global computer information network; downloadable computer operating system software; recorded computer operating system software

Class 42

New pharmaceutical research and development; drug discovery services; conducting early evaluations in the field of new pharmaceuticals; research relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; laboratory research in the field of pharmaceuticals; research and development of vaccines and medicines; medicine research; providing information on research and development of new products, namely, information on the testing, inspection, and research of medical products; scientific research in the field of pharmaceuticals; scientific research in the fields of biomedicine; development of computer software for drug discovery; development and creation of computer programmes for data processing; providing online non downloadable software for drug discovery; providing online non downloadable software for diagnosing diseases for medical purposes; providing online non downloadable software for processing, searching, and creating data; providing online non downloadable software for accessing information directories that may be downloaded from the global computer network; providing online non downloadable software for use in providing multiple user access to a global computer information network; rental of software for drug discovery; updating and adapting of computer programs according to user requirements; software as a service (SaaS) featuring software for drug discovery; software as a service (SaaS) featuring software for diagnosing diseases for medical purposes; software as a service (SaaS) featuring software for processing, searching, and creating data; software as a service (SaaS) featuring software for accessing information directories that may be downloaded from the global computer network; software as a service (SaaS) featuring software for use in providing multiple user access to a global computer information network; providing PaaS (platform as a service) featuring software for drug discovery; providing PaaS (platform as a service) featuring software for diagnosing diseases for medical purposes; providing PaaS (platform as a service) featuring software for processing, searching, and creating data; providing PaaS (platform as a service) featuring software for accessing information directories that may be downloaded from the global computer network; providing PaaS (platform as a service) featuring software for use in providing multiple user access to a global computer information network

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/15/2024

PUBO

PUBLISHED FOR OPPOSITION

10/15/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/25/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

02/16/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/13/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/26/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/26/2024

ALIE

ASSIGNED TO LIE

01/26/2024

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/07/2023

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

09/07/2023

GNSI

INQUIRY TO SUSPENSION E-MAILED

09/07/2023

CNSI

SUSPENSION INQUIRY WRITTEN

09/07/2023

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/21/2023

GNSL

LETTER OF SUSPENSION E-MAILED

02/21/2023

CNSL

SUSPENSION LETTER WRITTEN

02/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/26/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/25/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/25/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/26/2022

GNRT

NON-FINAL ACTION E-MAILED

07/26/2022

CNRT

NON-FINAL ACTION WRITTEN

07/26/2022

DOCK

ASSIGNED TO EXAMINER

07/21/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/04/2021

NWAP

NEW APPLICATION ENTERED

10/19/2021

Continuous trademark protection

Get notified about every new filing that threatens CIMPLRX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.